THUMPD1 and cancer: To explore the effect of THUMPD1 on immune response in tumor tissues, we evaluated the correlations between THUMPD1 expression and TMB, MSI and neoantigen, which are reportedly prognostic biomarkers of cancer immunotherapy [28,29].